Corvus Pharmaceuticals (CRVS) Profit After Tax (2015 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly Profit After Tax came in at -$13.9 million in Q1 2026, down 191.43% year-on-year from $15.2 million in Q1 2025, and down 37.07% quarter-over-quarter from -$10.2 million in Q3 2025.
Corvus Pharmaceuticals (CRVS) Profit After Tax (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Profit After Tax history runs 12 years deep, the most recent figure standing at -$13.9 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 191.43% year-over-year to -$13.9 million in Q1 2026; TTM through Mar 2026 was -$16.8 million, a 50.93% increase from a year earlier, with the FY2025 full-year figure at -$102.1 million, down 12.78% from the prior year.
- Profit After Tax fell to -$13.9 million in Q1 2026 per CRVS's latest filing, from -$10.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $15.2 million in Q1 2025 and bottomed at -$39.6 million in Q3 2024.
- The 5-year median for Profit After Tax is -$7.9 million (2023), against an average of -$8.7 million.
- Across the five-year window, Profit After Tax sank 560.0% in 2024 and jumped 367.09% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$6.8 million in 2022, then rose by 14.95% to -$5.7 million in 2023, then plunged by 589.42% to -$39.6 million in 2024, then soared by 74.35% to -$10.2 million in 2025, then sank by 37.07% to -$13.9 million in 2026.
- Per Business Quant, the three latest CRVS Profit After Tax figures stand at -$13.9 million (Q1 2026), -$10.2 million (Q3 2025), and -$8.0 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | -13.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.92 Mn |
| Sep 30, 2025 | -10.16 Mn |
| Jun 30, 2025 | -8.00 Mn |
| Mar 31, 2025 | 15.23 Mn |
| Sep 30, 2024 | -39.60 Mn |
| Jun 30, 2024 | -4.26 Mn |
| Mar 31, 2024 | -5.70 Mn |
| Dec 31, 2023 | -5.74 Mn |
| Sep 30, 2023 | -6.00 Mn |
| Jun 30, 2023 | -6.50 Mn |
| Mar 31, 2023 | -7.87 Mn |
| Dec 31, 2022 | -6.75 Mn |
| Sep 30, 2022 | -14.83 Mn |
| Jun 30, 2022 | -8.36 Mn |
| Mar 31, 2022 | -8.30 Mn |
| Dec 31, 2021 | -10.57 Mn |
| Sep 30, 2021 | -10.69 Mn |
| Jun 30, 2021 | -11.75 Mn |
| Mar 31, 2021 | -11.58 Mn |
| Dec 31, 2020 | 27.35 Mn |